Genentech, Inc.;Constellation Pharmaceuticals, Inc.
发明人:
申请号：
EP15848282.8
公开号：
EP3204360A4
申请日:
2015.10.10
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
and to salts thereof, wherein A has any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.
